# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

> **NCT00002858** · PHASE3 · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 280 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002858
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1993-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002858, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00002858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*